Letter to the Editor: Immunogenicity After the Third Dose of COVID-19 Vaccine in Cardiac Transplantation
- PMID: 37899474
- PMCID: PMC10664776
- DOI: 10.1097/TP.0000000000004843
Letter to the Editor: Immunogenicity After the Third Dose of COVID-19 Vaccine in Cardiac Transplantation
Conflict of interest statement
The authors declare no funding or conflicts of interest.
Figures

References
-
- Tran A, Fixler D, Huang R, et al. . Donor-specific HLA alloantibodies: impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation. J Heart Lung Transplant. 2016;35:87–91. - PubMed
-
- Centers for Disease Control and Prevention. Covid-19 vaccines for people who are moderately or severely immunocompromised. 2023. Available at https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immun.... Accessed June 20, 2023.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical